STUDY OF THE MECHANISM OF PULMONOTOXICOLOGICAL ACTION OF CARBONYL DICHLORIDE
- Авторлар: Tolkach P.G.1
-
Мекемелер:
- S.M. Kirov Military Medical Academy, Ministry of Defence of the Russian Federation
- Шығарылым: № 3 (2020)
- Беттер: 26-32
- Бөлім: Competition of scientific works of young scientists and specialists
- ##submission.datePublished##: 24.06.2020
- URL: https://vestnik.nvsu.ru/0869-7922/article/view/641244
- DOI: https://doi.org/10.36946/0869-7922-2020-3-26-32
- ID: 641244
Дәйексөз келтіру
Толық мәтін
Аннотация
Accidents at industrial facilities that use phosgene as a feedstock for the synthesis of chemical compounds can become a source of formation of a persistent focus of chemical contamination. Phosgene has an acylating effect on the macromolecules of the components of the aerogematic barrier, which leads to the development of toxic pulmonary edema. To date, it is not known which component of the aerogematic barrier (surfactant layer, alveolocytes or endotheliocytes) serves as the primary target for this toxicant. It has been found in vitro that the action of phosgene on the surfactant (Biosurf Ltd., Russian Federation) did not lead to a decrease in the content of main phospholipids (dipalmitoylphosphatidylcholine), but contributed to an increase in the content of compounds from the group of lysophosphatidylethanolamines (proinflammatory agents). In in vivo study with intraperitoneal administration of phosgene to laboratory animals (rats), there were no signs of an inflammatory reaction of the components of the mesentery of the small intestine. Pathological changes in the lungs and liver of animals that received phosgene intraperitoneal were also not detected.
The results of the study indicate that endotheliocytes located in the aerogematic barrier do not play a leading role in the initiation of a proinflammatory cascade in lung tissues after inhaled exposure to phosgene. The primary sources of proinflammatory mediators that lead to the development of toxic pulmonary edema may be alveolocytes and/or surfactant components.
Негізгі сөздер
Авторлар туралы
P. Tolkach
S.M. Kirov Military Medical Academy, Ministry of Defence of the Russian Federation
Хат алмасуға жауапты Автор.
Email: pgtolkach@gmail.com
Tolkach Pavel Gennad`evich
194044, Saint Petersburg
РесейӘдебиет тізімі
- Global Phosgene Market 2017. Digital Journal. 2017. Available at: http://www.digitaljournal.com/pr/3387723 (accessed 3 March 2019).
- Sciuto A.M., Hurt H.H. Therapeutic treatments of phosgene-induced lung injury. Inhal. Toxicol. 2004; 16: 565-80.
- Lange D.W., Meulenbelt J. Do corticosteroids have a role in preventing or reducing acute toxic lung injury caused by inhalation of chemical agents? Clin. Toxicol. 2011; 49: 61-71.
- Holmes W.W., Keyser B.M., Paradiso D.C., Ray R. Andres D.K., Benton B.J. [et al.] Conceptual approaches for treatment of phosgene inhalation-induced lung injury. Toxicol. Lett. 2016; 244: 8-20.
- Rozenberg O.A. Pulmonary surfactants for acute and chronic lung diseases (Part I). General Reanimatology. 2014; 10(3): 51-73 (in Russian).
- Schmidt R., Meier U, Yabut-Perez M., Walmrath D. Grimminger F, Seeger W. [et al.] Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia / Am J Respir Crit Care Med. 2001; 163: 95-100.
- Khurtsilava O.G. ed. Oxidative stress and inflammation: pathogenic partnership. SPb, NWSMU named after I.I. Mechnikov; 2012 (in Russian).
- Erohin V.V., Lepeha L.N., Erohina M.V., Lovacheva O.V. Surfactant system for pulmonary tuberculosis. M .: FSBI «TsNIIT» RAMS; 2013 (in Russian).
- Mills S.E. ed. Histology for pathologists, 3rd ed. Lippincott Willis & Wilkins, 2007: 547-562.
- Nagel W., Kuschinsky W. Study of the permeability of the isolated dog mesentery. Europ. J. Clin. Invest. 1970; 1: 149-54.
- Suárez-García S., Arola L., PascualSerrano A., Arola-Arnal A., Aragonès G., Bladé C. [et al.] Development and validation of a UHPLC-ESI-MS/MS method for the simultaneous quantification of mammal lysophosphatidylcholines and lysophosphatidylethanolamines in serum. Journal of Chromatography. 2017; 1055- 1056: 86–97.
- Filipczak P.T., Senft A.P., Seagrave J.C., Weber W., Kuehl P.J., Fredenburgh L.E. [et al]. NOS-2 inhibition in phosgene-induced acute lung injury. Toxicol. Scien. 2015; 146(1): 89-100.
Қосымша файлдар
